CrossRef Prognostic Significance of Intraindividual CT and MRI LI-RADS Agreement and Discordance in Hepatocellular Carcinoma Yong Jun Jung, Seokhwi Kim, In Hye Song, Ju Hyun Shim, Seung Soo Lee, Subin Heo, Sang Hyun Choi Radiology: Imaging Cancer .2026;[Epub] CrossRef Functional characterization of triokinase/FMN cyclase as a ferroptosis regulator and potential direct target of icaritin in hepatocellular carcinoma Wenpei Guo, Haiyan Yue, Chunan Zhou, Jiefeng He, Lixin Liu International Journal of Biological Macromolecules .2026
FUNDING STATEMENT This project was supported through grants awarded by the National Institutes of Health: R01HL46716, R01HL128831, and T32HL160517
GLP-1 RAs are designed to last much longer, from the time you take one dose until the time the next is due
Consuming protein beyond these amounts at a single meal does not proportionally increase muscle synthesis
Month 3 and Beyond: Long-Term Weight Loss Expectations Clinical trial data shows that patients using GLP-1 medications maintain an average weight loss of 15 to 22% of their starting body weight after 6 months of consistent use
PubMed May DC, Jarboe CH, VanBakel AB, Williams WM
.png)
